Neuroprotection: the end of an era?
D000818:Animals; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy*; D017211:Treatment Failure
D018696:Neuroprotective Agents